Inside the Mafia of Pharma Pricing - BIG by Matt Stoller
4% of all the money in America flows through a few mafia-like health care conglomerates. The FTC just released a ground-breaking report on how they operate. And it is gearing up to sue.
Inside the Mafia of Pharma Pricing 4% of all the money in America flows through a few mafia-like health care conglomerates. The FTC just released a ground-breaking report on how they operate. And it is gearing up to sue. Matt Stoller Jul 15, 2024 338 17 48 Share Welcome to BIG, a newsletter on the politics of monopoly power. If you’d like to sign up to receive issues over email, you can do so here . In 2022, an executive at a health insurance company expressed concern at the games his company was playing with drug prices. He pointed at the drug Gleevec, which when it was approved in 2001, was
saved by
related reading
- How Mark Cuban Is Trying to Disrupt Big Pharma | WSJyoutube.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Antitrust in the Digital Age: A Tale of Two Agencies - American Affairs Journalamericanaffairsjournal.org
- Curious cases of financial engineering in biotechowlposting.com
- Vincent Songvincentsong.posthaven.com
- How PBMs can use private-labelled drug products as a great escape from anti-steering policies - 46brooklyn Research46brooklyn.com
- The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
- PBM aka Perfect Business Model (Part 1)substack.com
- How pharmacies, drug makers, PBMs and health plans are benefiting from your Rx benefits!healthtechstack.io
- Why Medical Bills In The U.S. Are Out Of Controlyoutube.com
- What a time to be an oncologist - by Olivia Webb Kosloffacutecondition.com
- The Cantillon Effect and Credit Cards: The $257 Billion Payments Messmattstoller.substack.com